Boardroom Alpha
Meeting calendar
G · Annual meeting · Thursday, April 23, 2026

Genpact Ltd

10 nominees · 3 ballot items.

Elect ten directors to serve until the next annual election; approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers (say-on-pay); and approve the appointment of KPMG as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Market cap
$5.2B
1Y TSR
-34.1%
Board grade
C
Record date
Feb 27, 2026
Filing
DEF 14A
Meeting concluded · Apr 23, 2026

Follow how the vote landed and what changed on Genpact Ltd’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of directors

    ManagementBoard: FOR

    Elect ten (10) directors to hold office until the next annual election or the election and qualification of their successors.

  2. 2

    Non-binding vote on executive compensation

    ManagementBoard: FOR

    Advisory (non-binding) vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.

    More detail

    This proposal asks shareholders to cast an advisory vote approving the Company’s named executive officer (NEO) compensation as disclosed in the proxy statement (a so-called “say-on-pay” vote). Management is seeking this advisory approval to demonstrate and validate alignment between executive pay and corporate strategy, long-term performance, and shareholder interests; while the vote is non-binding, the board and compensation committee state they will consider the outcome when making future compensation decisions. The proxy materials describe a pay program that emphasizes performance-based incentives (PSUs and annual bonuses) and time-based RSUs, with a multi-year PSU design incorporating revenue and adjusted diluted EPS targets and a relative TSR modifier to link pay to shareholder returns. Notably, the company implemented substantive changes in 2023 in response to shareholder feedback (three‑year PSU periods, annual RSUs instead of periodic options, rTSR modifier), and the company reports high historical support for its say-on-pay proposals (approximately high 80s-to-90s percent range in recent years). Potential shareholder concerns include the absolute level and mix of CEO pay (including a one-time retention RSU granted to the CEO in December 2025), the degree to which short‑term versus long‑term incentives drive behavior, and the measurement choices (revenue and Adjusted EPS weightings, AOI margin and employee engagement in bonus funding). Management’s stated rationale is that the program incentivizes sustainable, long-term value creation, aligns management with shareholders through substantial equity exposure and share ownership guidelines, and includes governance features such as clawbacks and caps to limit excessive risk-taking. Because the vote is advisory, a negative result would not automatically change pay outcomes but would trigger engagement and likely prompt the compensation committee to review plan design and disclosures; conversely, strong shareholder support validates the committee’s approach and reduces near-term pressure for material redesign. Overall, the proposal sits at the intersection of governance signaling and compensation design: it is a mechanism for shareholders to express assent or concern about pay practices that materially affect retention, incentive alignment, and long-term strategy execution. The board recommends a “FOR” vote, arguing that the compensation program is appropriately structured to drive performance while incorporating shareholder feedback and governance safeguards.

  3. 3

    Approval of appointment of independent registered public accounting firm

    ManagementBoard: FOR

    Approve the appointment of KPMG Assurance and Consulting Services LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Director elections

Nominees on the ballot10

Independent
Tenure on this board
1.9 yrs
Also a director at
Nucor Corp (NUE)Amrize Ltd (AMRZ)
Independent
Tenure on this board
1.1 yrs
Also a director at
Sysco Corp (SYY)
Independent
Tenure on this board
10.1 yrs
Also a director at
Exponent Inc (EXPO)Everforth Inc (EFOR)
Independent
Tenure on this board
10.3 yrs
Also a director at
Wells Fargo & Company (WFC)
Ownership

Top institutional holders10

Latest 13F quarter
1Nalanda India Equity Fund Ltd8.1%13,702,500$510M
2FMR LLC7.7%13,006,782$485M
3AQR CAPITAL MANAGEMENT LLC6.6%11,179,378$416M
4VANGUARD PORTFOLIO MANAGEMENT LLC5.1%8,643,074$322M
5BlackRock, Inc.5.1%8,566,911$319M
6VANGUARD CAPITAL MANAGEMENT LLC4.4%7,457,930$278M
7DIMENSIONAL FUND ADVISORS LP3.0%5,150,795$192M
8STATE STREET CORP3.0%5,093,105$190M
9FMR LLC2.8%4,795,055$179M
10BlackRock, Inc.2.8%4,674,062$174M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Genpact Ltd 2026 annual meeting?
Genpact Ltd (G) holds its 2026 annual shareholder meeting on Thursday, April 23, 2026.
What is the record date for the Genpact Ltd 2026 meeting?
The record date for the Genpact Ltd 2026 meeting is Friday, February 27, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Genpact Ltd's 2026 meeting?
The board is presenting 10 director nominees at the Genpact Ltd 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Genpact Ltd 2026 meeting?
Shareholders will vote on 3 proposals at the Genpact Ltd 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer